Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for FDC
Revenue projections for FDC



Financial Ratios:

currentRatio 2.98300
forwardPE 0.00000
debtToEquity 0.85200
earningsGrowth -0.60500
revenueGrowth -0.07900
grossMargins 0.65678
operatingMargins 0.03936
trailingEps 13.86000
forwardEps 23.30000

With a current ratio of 2.983, FDC Limited has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that FDC Limited is in a strong position to meet its immediate financial obligations without difficulty.
FDC's low earnings and revenue growth point to a potential decline in profits. This signals a downturn in financial performance, suggesting that the company might face challenges in maintaining its current level of profitability.
FDC Limited's negative gross and operating margins point to financial difficulties, as the company is unable to generate profit from its core operations or production. This could signal broader problems in cost management or declining sales.
With a forward EPS greater than its trailing EPS, FDC is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.

Recommendation changes over time:

Recommendations trend for FDC
Recommendations trend for FDC


The recent buy bias from analysts suggests FDC is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, FDC appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.